0.1(2.16%) Volume: 2,257,670 9:08PM EST| Market Cap : 525.6 M | Enterprise Value : 13.84 B | P/E (TTM) : | P/B : |
|---|
NYSE:CYH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:CYH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash-to-Debt | 0.03 |
NYSE:CYH's Cash-to-Debt is ranked lower than
88% of the 274 Companies in the Global Medical Care industry. ( Industry Median: 0.28 vs. NYSE:CYH: 0.03 ) Ranked among companies with meaningful Cash-to-Debt only. |
NYSE:CYH'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.15 Current: 0.03 |
| Equity-to-Asset | -0.07 |
NYSE:CYH's Equity-to-Asset is ranked lower than
95% of the 269 Companies in the Global Medical Care industry. ( Industry Median: 0.48 vs. NYSE:CYH: -0.07 ) Ranked among companies with meaningful Equity-to-Asset only. |
NYSE:CYH'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.07 Med: 0.16 Max: 0.46 Current: -0.07 |
| Debt-to-Equity | -11.26 |
NYSE:CYH's Debt-to-Equity is ranked lower than
99.99% of the 202 Companies in the Global Medical Care industry. ( Industry Median: 0.64 vs. NYSE:CYH: -11.26 ) Ranked among companies with meaningful Debt-to-Equity only. |
NYSE:CYH'
s Debt-to-Equity Range Over the Past 10 Years
Min: -18.14 Med: 3.49 Max: 11.49 Current: -11.26 |
| Debt-to-EBITDA | -10.90 |
NYSE:CYH's Debt-to-EBITDA is ranked lower than
99.99% of the 201 Companies in the Global Medical Care industry. ( Industry Median: 2.81 vs. NYSE:CYH: -10.90 ) Ranked among companies with meaningful Debt-to-EBITDA only. |
NYSE:CYH'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -13.51 Med: 5.56 Max: 42.23 Current: -10.9 |
| Interest Coverage | 0.26 |
NYSE:CYH's Interest Coverage is ranked lower than
99.99% of the 227 Companies in the Global Medical Care industry. ( Industry Median: 6.85 vs. NYSE:CYH: 0.26 ) Ranked among companies with meaningful Interest Coverage only. |
NYSE:CYH'
s Interest Coverage Range Over the Past 10 Years
Min: 0.23 Med: 1.43 Max: 1.78 Current: 0.26 |
| Piotroski F-Score: 3 |
|
| Altman Z-Score: 0.31 |
|
| Beneish M-Score: -3.38 |
|
| WACC vs ROIC |
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating Margin % | 1.75 |
NYSE:CYH's Operating Margin % is ranked lower than
88% of the 272 Companies in the Global Medical Care industry. ( Industry Median: 6.83 vs. NYSE:CYH: 1.75 ) Ranked among companies with meaningful Operating Margin % only. |
NYSE:CYH'
s Operating Margin % Range Over the Past 10 Years
Min: 1.41 Med: 7.65 Max: 9.07 Current: 1.75 |
| Net Margin % | -17.97 |
NYSE:CYH's Net Margin % is ranked lower than
89% of the 272 Companies in the Global Medical Care industry. ( Industry Median: 3.88 vs. NYSE:CYH: -17.97 ) Ranked among companies with meaningful Net Margin % only. |
NYSE:CYH'
s Net Margin % Range Over the Past 10 Years
Min: -17.97 Med: 1.4 Max: 2.22 Current: -17.97 |
| ROA % | -14.09 |
NYSE:CYH's ROA % is ranked lower than
89% of the 273 Companies in the Global Medical Care industry. ( Industry Median: 3.48 vs. NYSE:CYH: -14.09 ) Ranked among companies with meaningful ROA % only. |
NYSE:CYH'
s ROA % Range Over the Past 10 Years
Min: -14.09 Med: 1.1 Max: 1.95 Current: -14.09 |
| ROC (Joel Greenblatt) % | -23.78 |
NYSE:CYH's ROC (Joel Greenblatt) % is ranked lower than
89% of the 272 Companies in the Global Medical Care industry. ( Industry Median: 14.91 vs. NYSE:CYH: -23.78 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
NYSE:CYH'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -23.78 Med: 13.88 Max: 16.43 Current: -23.78 |
| 3-Year Revenue Growth Rate | -6.00 |
NYSE:CYH's 3-Year Revenue Growth Rate is ranked lower than
85% of the 211 Companies in the Global Medical Care industry. ( Industry Median: 6.50 vs. NYSE:CYH: -6.00 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
NYSE:CYH'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -6 Med: 9.5 Max: 47.2 Current: -6 |
| Steven Cohen 2,223,900 sh (New) Paul Tudor Jones 40,210 sh (New) Jeremy Grantham 66,300 sh (+60.92%) | Ron Baron 100 sh (unchged) | Joel Greenblatt 165,286 sh (-74.25%) Chuck Royce 2,372,795 sh (-4.41%) Barrow, Hanley, Mewhinney & Strauss 131,807 sh (-70.34%) |
| Lee Ainslie 248,450 sh (New) | Ron Baron 100 sh (unchged) | Joel Greenblatt Sold Out Jeremy Grantham Sold Out Steven Cohen Sold Out Paul Tudor Jones Sold Out Chuck Royce 1,579,895 sh (-33.42%) Barrow, Hanley, Mewhinney & Strauss 131,449 sh (-0.27%) |
| Joel Greenblatt 91,563 sh (New) | George Soros 570,000 sh (unchged) Ron Baron 100 sh (unchged) | Lee Ainslie Sold Out Barrow, Hanley, Mewhinney & Strauss Sold Out Chuck Royce 1,467,395 sh (-7.12%) |
| Paul Singer 4,500,000 sh (New) Chuck Royce 2,299,895 sh (+56.73%) Joel Greenblatt 116,177 sh (+26.88%) | Ron Baron 100 sh (unchged) |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
| Guru | Date | Action |
Impact | Price Range (Average)* |
Change from Average | Comment | Current Shares |
|---|
What is Peter Lynch Charts )| Industry: | Health Care Providers » Medical Care NAICS: 622110 SIC: 8062 | |
|---|---|---|
| Compare: | LSE:CMBN, LSE:CTH, HKSE:02138, BKK:CMR, SGX:588, HKSE:01526, ASX:GXL, SGX:RF1U, NSE:HCG, LSE:GHG, XSGO:LAS CONDES, HKSE:02120, HKSE:03689, NAS:AMEH, SGX:QC7, OHEL:PIHLIS, HKSE:03869, BOM:540797, XTER:MED, ASX:VRT » details | |
| Traded in other countries: | CG5.Germany, | |
| Headquarter Location: | USA |
| vs
industry |
vs
history |
||
|---|---|---|---|
| PS Ratio | 0.04 |
CYH's PS Ratio is ranked higher than
99% of the 262 Companies in the Global Medical Care industry. ( Industry Median: 1.70 vs. CYH: 0.04 ) Ranked among companies with meaningful PS Ratio only. |
CYH'
s PS Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.18 Max: 0.4 Current: 0.04 |
| Price-to-Free-Cash-Flow | 10.89 |
CYH's Price-to-Free-Cash-Flow is ranked higher than
97% of the 135 Companies in the Global Medical Care industry. ( Industry Median: 23.01 vs. CYH: 10.89 ) Ranked among companies with meaningful Price-to-Free-Cash-Flow only. |
CYH'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.12 Med: 7.16 Max: 77.96 Current: 10.89 |
| Price-to-Operating-Cash-Flow | 0.84 |
CYH's Price-to-Operating-Cash-Flow is ranked higher than
99% of the 186 Companies in the Global Medical Care industry. ( Industry Median: 14.67 vs. CYH: 0.84 ) Ranked among companies with meaningful Price-to-Operating-Cash-Flow only. |
CYH'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.49 Med: 1.92 Max: 4.9 Current: 0.84 |
| EV-to-EBIT | -7.01 |
CYH's EV-to-EBIT is ranked lower than
99.99% of the 214 Companies in the Global Medical Care industry. ( Industry Median: 21.68 vs. CYH: -7.01 ) Ranked among companies with meaningful EV-to-EBIT only. |
CYH'
s EV-to-EBIT Range Over the Past 10 Years
Min: -23.6 Med: 10.2 Max: 30.9 Current: -7.01 |
| EV-to-EBITDA | -11.10 |
CYH's EV-to-EBITDA is ranked lower than
99.99% of the 228 Companies in the Global Medical Care industry. ( Industry Median: 15.23 vs. CYH: -11.10 ) Ranked among companies with meaningful EV-to-EBITDA only. |
CYH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.4 Med: 7.1 Max: 675.4 Current: -11.1 |
| EV-to-Revenue | 1.01 |
CYH's EV-to-Revenue is ranked higher than
82% of the 271 Companies in the Global Medical Care industry. ( Industry Median: 2.17 vs. CYH: 1.01 ) Ranked among companies with meaningful EV-to-Revenue only. |
CYH'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8 Med: 1 Max: 1.7 Current: 1.01 |
| Current Ratio | 1.50 |
CYH's Current Ratio is ranked higher than
63% of the 260 Companies in the Global Medical Care industry. ( Industry Median: 1.34 vs. CYH: 1.50 ) Ranked among companies with meaningful Current Ratio only. |
CYH'
s Current Ratio Range Over the Past 10 Years
Min: 1.28 Med: 1.75 Max: 2.34 Current: 1.5 |
| Quick Ratio | 1.33 |
CYH's Quick Ratio is ranked higher than
61% of the 260 Companies in the Global Medical Care industry. ( Industry Median: 1.24 vs. CYH: 1.33 ) Ranked among companies with meaningful Quick Ratio only. |
CYH'
s Quick Ratio Range Over the Past 10 Years
Min: 1.14 Med: 1.56 Max: 2.14 Current: 1.33 |
| Days Sales Outstanding | 62.26 |
CYH's Days Sales Outstanding is ranked lower than
70% of the 227 Companies in the Global Medical Care industry. ( Industry Median: 39.87 vs. CYH: 62.26 ) Ranked among companies with meaningful Days Sales Outstanding only. |
CYH'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.58 Med: 57.74 Max: 67.81 Current: 62.26 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.60 |
CYH's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 159 Companies in the Global Medical Care industry. ( Industry Median: -2.50 vs. CYH: 0.60 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
CYH'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.9 Med: 0.35 Max: 3.8 Current: 0.6 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price-to-Median-PS-Value | 0.21 |
CYH's Price-to-Median-PS-Value is ranked higher than
98% of the 208 Companies in the Global Medical Care industry. ( Industry Median: 1.03 vs. CYH: 0.21 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
CYH'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14 Med: 1.38 Max: 10.25 Current: 0.21 |
| Earnings Yield (Greenblatt) % | -14.26 |
CYH's Earnings Yield (Greenblatt) % is ranked lower than
93% of the 273 Companies in the Global Medical Care industry. ( Industry Median: 3.61 vs. CYH: -14.26 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
CYH'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -14.7 Med: 7.4 Max: 11.2 Current: -14.26 |
| Forward Rate of Return (Yacktman) % | -89.20 |
CYH's Forward Rate of Return (Yacktman) % is ranked lower than
99% of the 133 Companies in the Global Medical Care industry. ( Industry Median: 9.10 vs. CYH: -89.20 ) Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only. |
CYH'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -94.7 Med: 18.25 Max: 84.6 Current: -89.2 |
| Revenue (TTM) (Mil) $ | 13,760.00 |
|---|---|
| EPS (TTM) $ | -22.08 |
| Beta | 3.89 |
| Volatility | 74.41% |
| 52-Week Range $ | 2.48 - 6.36 |
| Shares Outstanding (Mil) | 116.28 |
| Dec18 | Dec19 | Dec20 | |
|---|---|---|---|
| Revenue (Mil $) | 14,088 | 12,972 | 12,916 |
| EBIT (Mil $) | 918 | 1,067 | 884 |
| EBITDA (Mil $) | 1,623 | 1,576 | 1,572 |
| EPS ($) | -2.95 | -1.53 | -1.07 |
| EPS without NRI ($) | -2.95 | -1.53 | -1.07 |
| EPS Growth Rate (Future 3Y To 5Y Estimate) | N/A | ||
| Dividends per Share ($) | |||
|
GF Chat
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP